Sync template from atomicqms-style deployment
This commit is contained in:
0
Forms/Audit-Forms/.gitkeep
Normal file
0
Forms/Audit-Forms/.gitkeep
Normal file
0
Forms/Consent-Templates/.gitkeep
Normal file
0
Forms/Consent-Templates/.gitkeep
Normal file
64
Forms/FRM-001-Document-Change-Request.md
Normal file
64
Forms/FRM-001-Document-Change-Request.md
Normal file
@@ -0,0 +1,64 @@
|
||||
# Document Change Request Form
|
||||
|
||||
| Form ID | FRM-001 | Revision | 1.0 |
|
||||
|---------|---------|----------|-----|
|
||||
|
||||
---
|
||||
|
||||
## Section 1: Request Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Request Date | |
|
||||
| Requested By | |
|
||||
| Department | |
|
||||
|
||||
## Section 2: Document Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Document Number | |
|
||||
| Document Title | |
|
||||
| Current Revision | |
|
||||
|
||||
## Section 3: Change Description
|
||||
|
||||
### Type of Change
|
||||
- [ ] New Document
|
||||
- [ ] Revision to Existing Document
|
||||
- [ ] Document Obsolescence
|
||||
|
||||
### Description of Change
|
||||
*(Describe the proposed change in detail)*
|
||||
|
||||
|
||||
|
||||
|
||||
### Reason for Change
|
||||
*(Explain why this change is needed)*
|
||||
|
||||
|
||||
|
||||
|
||||
## Section 4: Impact Assessment
|
||||
|
||||
### Affected Areas
|
||||
- [ ] Training Required
|
||||
- [ ] Other Documents Affected
|
||||
- [ ] Process Changes Required
|
||||
- [ ] Validation Impact
|
||||
|
||||
### List Affected Documents
|
||||
|
||||
|
||||
## Section 5: Approvals
|
||||
|
||||
| Role | Name | Signature | Date |
|
||||
|------|------|-----------|------|
|
||||
| Requester | | | |
|
||||
| Document Owner | | | |
|
||||
| Quality Assurance | | | |
|
||||
|
||||
---
|
||||
|
||||
*Form FRM-001 Rev 1.0*
|
||||
91
Forms/FRM-003-CAPA-Form.md
Normal file
91
Forms/FRM-003-CAPA-Form.md
Normal file
@@ -0,0 +1,91 @@
|
||||
# Corrective and Preventive Action (CAPA) Form
|
||||
|
||||
| Form ID | FRM-003 | Revision | 1.0 |
|
||||
|---------|---------|----------|-----|
|
||||
|
||||
---
|
||||
|
||||
## Section 1: CAPA Identification
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| CAPA Number | |
|
||||
| Date Initiated | |
|
||||
| Initiated By | |
|
||||
| CAPA Owner | |
|
||||
| Target Closure Date | |
|
||||
|
||||
## Section 2: Classification
|
||||
|
||||
### Type
|
||||
- [ ] Corrective Action
|
||||
- [ ] Preventive Action
|
||||
|
||||
### Source
|
||||
- [ ] Customer Complaint
|
||||
- [ ] Internal Audit
|
||||
- [ ] External Audit
|
||||
- [ ] Process Deviation
|
||||
- [ ] Nonconforming Product
|
||||
- [ ] Management Review
|
||||
- [ ] Other: ____________
|
||||
|
||||
### Priority
|
||||
- [ ] Critical (5 business days)
|
||||
- [ ] Major (15 business days)
|
||||
- [ ] Minor (30 business days)
|
||||
|
||||
## Section 3: Problem Description
|
||||
|
||||
*(Describe the nonconformity or potential nonconformity)*
|
||||
|
||||
|
||||
|
||||
|
||||
## Section 4: Immediate Containment
|
||||
|
||||
*(Actions taken to contain the immediate impact)*
|
||||
|
||||
|
||||
|
||||
|
||||
## Section 5: Root Cause Investigation
|
||||
|
||||
### Investigation Method Used
|
||||
- [ ] 5 Whys
|
||||
- [ ] Fishbone Diagram
|
||||
- [ ] Fault Tree Analysis
|
||||
- [ ] Other: ____________
|
||||
|
||||
### Root Cause Determination
|
||||
|
||||
|
||||
|
||||
|
||||
## Section 6: Corrective/Preventive Actions
|
||||
|
||||
| Action | Responsible | Due Date | Status |
|
||||
|--------|-------------|----------|--------|
|
||||
| | | | |
|
||||
| | | | |
|
||||
| | | | |
|
||||
|
||||
## Section 7: Effectiveness Verification
|
||||
|
||||
| Criteria | Method | Result |
|
||||
|----------|--------|--------|
|
||||
| | | |
|
||||
|
||||
Verification Date: ____________
|
||||
Verified By: ____________
|
||||
|
||||
## Section 8: Closure
|
||||
|
||||
| Role | Name | Signature | Date |
|
||||
|------|------|-----------|------|
|
||||
| CAPA Owner | | | |
|
||||
| Quality Approval | | | |
|
||||
|
||||
---
|
||||
|
||||
*Form FRM-003 Rev 1.0*
|
||||
56
Forms/FRM-006-Audit-Checklist.md
Normal file
56
Forms/FRM-006-Audit-Checklist.md
Normal file
@@ -0,0 +1,56 @@
|
||||
# Internal Audit Checklist
|
||||
|
||||
| Form ID | FRM-006 | Revision | 1.0 |
|
||||
|---------|---------|----------|-----|
|
||||
|
||||
---
|
||||
|
||||
## Audit Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Audit Number | |
|
||||
| Audit Date | |
|
||||
| Area/Process Audited | |
|
||||
| Lead Auditor | |
|
||||
| Auditee(s) | |
|
||||
|
||||
---
|
||||
|
||||
## Checklist Items
|
||||
|
||||
| # | Requirement/Question | Reference | C/NC/NA | Evidence/Notes |
|
||||
|---|---------------------|-----------|---------|----------------|
|
||||
| 1 | Are current versions of applicable procedures available? | SOP-001 | | |
|
||||
| 2 | Are personnel trained on applicable procedures? | SOP-003 | | |
|
||||
| 3 | Are training records current and complete? | SOP-003 | | |
|
||||
| 4 | Are records properly maintained and retrievable? | SOP-001 | | |
|
||||
| 5 | Are nonconformities being documented and addressed? | SOP-002 | | |
|
||||
| 6 | Are CAPAs being completed on time? | SOP-002 | | |
|
||||
| 7 | Is equipment calibrated and maintained? | | | |
|
||||
| 8 | Are process controls being followed? | | | |
|
||||
| 9 | Are quality objectives being monitored? | | | |
|
||||
| 10 | | | | |
|
||||
|
||||
**Legend:** C = Conforming, NC = Nonconforming, NA = Not Applicable
|
||||
|
||||
---
|
||||
|
||||
## Findings Summary
|
||||
|
||||
| Finding # | Type | Description | Clause Reference |
|
||||
|-----------|------|-------------|------------------|
|
||||
| | | | |
|
||||
| | | | |
|
||||
|
||||
---
|
||||
|
||||
## Auditor Signature
|
||||
|
||||
| Auditor | Signature | Date |
|
||||
|---------|-----------|------|
|
||||
| | | |
|
||||
|
||||
---
|
||||
|
||||
*Form FRM-006 Rev 1.0*
|
||||
0
Forms/Reporting-Forms/.gitkeep
Normal file
0
Forms/Reporting-Forms/.gitkeep
Normal file
0
Forms/Review-Checklists/.gitkeep
Normal file
0
Forms/Review-Checklists/.gitkeep
Normal file
0
Forms/Submission-Forms/.gitkeep
Normal file
0
Forms/Submission-Forms/.gitkeep
Normal file
434
Forms/Submissions/FRM-IRB-001-Protocol-Submission-Form.md
Normal file
434
Forms/Submissions/FRM-IRB-001-Protocol-Submission-Form.md
Normal file
@@ -0,0 +1,434 @@
|
||||
# IRB Protocol Submission Form
|
||||
|
||||
| Form ID | FRM-IRB-001 | Revision | 1.0 |
|
||||
|---------|-------------|----------|-----|
|
||||
|
||||
---
|
||||
|
||||
## Section 1: General Information
|
||||
|
||||
### 1.1 Submission Type
|
||||
|
||||
☐ New Protocol
|
||||
☐ Modification/Amendment to Protocol #: _____________
|
||||
☐ Continuing Review for Protocol #: _____________
|
||||
|
||||
### 1.2 Study Identification
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Protocol Title | |
|
||||
| Short Title (≤50 characters) | |
|
||||
| Proposed Start Date | |
|
||||
| Expected Duration | months |
|
||||
|
||||
### 1.3 Review Category Requested
|
||||
|
||||
☐ Exempt (specify category): _____________
|
||||
☐ Expedited (specify category): _____________
|
||||
☐ Full Board Review
|
||||
|
||||
---
|
||||
|
||||
## Section 2: Principal Investigator Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Name | |
|
||||
| Title/Position | |
|
||||
| Department | |
|
||||
| Institution | |
|
||||
| Mailing Address | |
|
||||
| Phone | |
|
||||
| Email | |
|
||||
| Faculty Sponsor (if PI is student) | |
|
||||
|
||||
**Training Certification:**
|
||||
| Certification | Expiration Date |
|
||||
|---------------|-----------------|
|
||||
| CITI Human Subjects | |
|
||||
| GCP (if applicable) | |
|
||||
| Other: | |
|
||||
|
||||
---
|
||||
|
||||
## Section 3: Research Team
|
||||
|
||||
| Name | Role | Department | Training Current? |
|
||||
|------|------|------------|-------------------|
|
||||
| | PI | | ☐ Yes |
|
||||
| | | | ☐ Yes |
|
||||
| | | | ☐ Yes |
|
||||
| | | | ☐ Yes |
|
||||
| | | | ☐ Yes |
|
||||
|
||||
---
|
||||
|
||||
## Section 4: Funding Information
|
||||
|
||||
### 4.1 Funding Source
|
||||
|
||||
☐ Internally Funded (Department/Institution)
|
||||
☐ Federal Grant (Agency: _____________)
|
||||
☐ Industry Sponsored (Sponsor: _____________)
|
||||
☐ Foundation/Non-Profit (Name: _____________)
|
||||
☐ Not Funded
|
||||
|
||||
### 4.2 Grant Information (if applicable)
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Grant/Contract Number | |
|
||||
| Funding Period | |
|
||||
| Grant Title | |
|
||||
|
||||
---
|
||||
|
||||
## Section 5: Study Overview
|
||||
|
||||
### 5.1 Purpose and Objectives
|
||||
|
||||
*Briefly describe the purpose of this research and specific aims (250 words max):*
|
||||
|
||||
### 5.2 Background and Rationale
|
||||
|
||||
*Provide scientific background and justification (500 words max):*
|
||||
|
||||
### 5.3 Research Design
|
||||
|
||||
☐ Observational/Non-interventional
|
||||
☐ Interventional
|
||||
☐ Clinical Trial
|
||||
☐ Survey/Questionnaire
|
||||
☐ Interview/Focus Group
|
||||
☐ Secondary Data Analysis
|
||||
☐ Other: _____________
|
||||
|
||||
---
|
||||
|
||||
## Section 6: Subject Population
|
||||
|
||||
### 6.1 Target Population
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Minimum Age | |
|
||||
| Maximum Age | |
|
||||
| Target Enrollment (this site) | |
|
||||
| Target Enrollment (total, all sites) | |
|
||||
|
||||
### 6.2 Inclusion Criteria
|
||||
|
||||
*List specific inclusion criteria:*
|
||||
|
||||
1.
|
||||
2.
|
||||
3.
|
||||
4.
|
||||
5.
|
||||
|
||||
### 6.3 Exclusion Criteria
|
||||
|
||||
*List specific exclusion criteria:*
|
||||
|
||||
1.
|
||||
2.
|
||||
3.
|
||||
4.
|
||||
5.
|
||||
|
||||
### 6.4 Vulnerable Populations
|
||||
|
||||
*Check all that may be included:*
|
||||
|
||||
☐ None
|
||||
☐ Children/Minors
|
||||
☐ Prisoners
|
||||
☐ Pregnant Women
|
||||
☐ Cognitively Impaired
|
||||
☐ Economically Disadvantaged
|
||||
☐ Educationally Disadvantaged
|
||||
☐ Students of PI
|
||||
☐ Employees of PI
|
||||
☐ Decisionally Impaired
|
||||
☐ Other: _____________
|
||||
|
||||
*If vulnerable populations included, describe additional protections:*
|
||||
|
||||
---
|
||||
|
||||
## Section 7: Recruitment
|
||||
|
||||
### 7.1 Recruitment Methods
|
||||
|
||||
*Check all that apply:*
|
||||
|
||||
☐ Medical records review
|
||||
☐ Advertising (print, radio, TV)
|
||||
☐ Internet/Social media
|
||||
☐ Flyers/Posters
|
||||
☐ Direct approach in clinic
|
||||
☐ Telephone
|
||||
☐ Email
|
||||
☐ Referral from provider
|
||||
☐ Community outreach
|
||||
☐ Other: _____________
|
||||
|
||||
### 7.2 Recruitment Materials
|
||||
|
||||
*List all recruitment materials attached:*
|
||||
|
||||
| Document Name | Version/Date |
|
||||
|---------------|--------------|
|
||||
| | |
|
||||
| | |
|
||||
| | |
|
||||
|
||||
---
|
||||
|
||||
## Section 8: Research Procedures
|
||||
|
||||
### 8.1 Study Procedures
|
||||
|
||||
*Describe all procedures subjects will undergo (include timeline):*
|
||||
|
||||
### 8.2 Duration of Participation
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Number of visits | |
|
||||
| Duration of each visit | |
|
||||
| Total participation time | |
|
||||
| Follow-up duration | |
|
||||
|
||||
### 8.3 Study Location(s)
|
||||
|
||||
| Location | Address |
|
||||
|----------|---------|
|
||||
| | |
|
||||
| | |
|
||||
|
||||
---
|
||||
|
||||
## Section 9: Drugs, Devices, and Biologics
|
||||
|
||||
### 9.1 Does this study involve drugs, devices, or biologics?
|
||||
|
||||
☐ No → Skip to Section 10
|
||||
☐ Yes → Complete below
|
||||
|
||||
### 9.2 Drug Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Drug Name | |
|
||||
| IND Number (or Exemption) | |
|
||||
| FDA Approval Status | ☐ Approved ☐ Investigational |
|
||||
| IND Sponsor | |
|
||||
|
||||
### 9.3 Device Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Device Name | |
|
||||
| IDE Number (or Exemption) | |
|
||||
| FDA Approval Status | ☐ Approved ☐ Investigational ☐ Exempt |
|
||||
| Device Risk | ☐ Significant Risk ☐ Non-Significant Risk |
|
||||
|
||||
---
|
||||
|
||||
## Section 10: Risks and Benefits
|
||||
|
||||
### 10.1 Risks
|
||||
|
||||
*Describe all foreseeable risks (physical, psychological, social, economic, legal):*
|
||||
|
||||
| Risk | Likelihood | Severity | Mitigation |
|
||||
|------|------------|----------|------------|
|
||||
| | ☐ Low ☐ Med ☐ High | ☐ Low ☐ Med ☐ High | |
|
||||
| | ☐ Low ☐ Med ☐ High | ☐ Low ☐ Med ☐ High | |
|
||||
| | ☐ Low ☐ Med ☐ High | ☐ Low ☐ Med ☐ High | |
|
||||
|
||||
### 10.2 Benefits
|
||||
|
||||
*Describe potential benefits:*
|
||||
|
||||
**To subjects:**
|
||||
|
||||
**To others/society:**
|
||||
|
||||
### 10.3 Risk/Benefit Assessment
|
||||
|
||||
*Justify why risks are reasonable in relation to anticipated benefits:*
|
||||
|
||||
---
|
||||
|
||||
## Section 11: Privacy and Confidentiality
|
||||
|
||||
### 11.1 Identifiable Information Collected
|
||||
|
||||
*Check all that apply:*
|
||||
|
||||
☐ Name
|
||||
☐ Date of birth
|
||||
☐ Social Security Number
|
||||
☐ Medical Record Number
|
||||
☐ Address
|
||||
☐ Phone number
|
||||
☐ Email
|
||||
☐ Photographs/Video
|
||||
☐ Audio recordings
|
||||
☐ IP address
|
||||
☐ Genetic information
|
||||
☐ Other: _____________
|
||||
|
||||
### 11.2 Data Storage and Security
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Storage location | ☐ Paper ☐ Electronic ☐ Both |
|
||||
| Physical security measures | |
|
||||
| Electronic security measures | |
|
||||
| Who will have access to data? | |
|
||||
| Data retention period | |
|
||||
| Disposition after study | ☐ Destroy ☐ Archive |
|
||||
|
||||
### 11.3 Data Sharing
|
||||
|
||||
Will data be shared with others outside the research team?
|
||||
☐ No ☐ Yes (describe): _____________
|
||||
|
||||
---
|
||||
|
||||
## Section 12: Informed Consent
|
||||
|
||||
### 12.1 Consent Process
|
||||
|
||||
*Describe how consent will be obtained:*
|
||||
|
||||
☐ Written consent from subject
|
||||
☐ Written consent from LAR
|
||||
☐ Oral consent with documentation
|
||||
☐ Waiver of documentation of consent
|
||||
☐ Waiver of consent
|
||||
|
||||
### 12.2 Consent Documents
|
||||
|
||||
| Document | Language | Version/Date |
|
||||
|----------|----------|--------------|
|
||||
| Consent Form | | |
|
||||
| Consent Form | | |
|
||||
| Assent Form | | |
|
||||
| HIPAA Authorization | | |
|
||||
|
||||
### 12.3 Waivers Requested
|
||||
|
||||
**Waiver of Consent (45 CFR 46.116(f)):**
|
||||
☐ Not requested
|
||||
☐ Requested - Justify below:
|
||||
|
||||
**Waiver of Documentation of Consent (45 CFR 46.117(c)):**
|
||||
☐ Not requested
|
||||
☐ Requested - Justify below:
|
||||
|
||||
**Waiver of HIPAA Authorization (45 CFR 164.512(i)):**
|
||||
☐ Not requested
|
||||
☐ Requested - Justify below:
|
||||
|
||||
---
|
||||
|
||||
## Section 13: Compensation
|
||||
|
||||
### 13.1 Subject Compensation
|
||||
|
||||
☐ No compensation
|
||||
☐ Yes → Complete below
|
||||
|
||||
| Visit/Activity | Compensation Amount |
|
||||
|----------------|---------------------|
|
||||
| | $ |
|
||||
| | $ |
|
||||
| Total possible | $ |
|
||||
|
||||
### 13.2 Payment Method
|
||||
|
||||
☐ Cash ☐ Check ☐ Gift card ☐ Other: _____________
|
||||
|
||||
---
|
||||
|
||||
## Section 14: Conflict of Interest
|
||||
|
||||
### 14.1 Financial Interests
|
||||
|
||||
Does any member of the research team have a financial interest in the study sponsor, product, or outcome?
|
||||
|
||||
☐ No
|
||||
☐ Yes (disclosure attached)
|
||||
|
||||
---
|
||||
|
||||
## Section 15: Required Attachments Checklist
|
||||
|
||||
| Document | Attached? |
|
||||
|----------|-----------|
|
||||
| Research Protocol | ☐ |
|
||||
| Informed Consent Form(s) | ☐ |
|
||||
| Assent Form(s) | ☐ or N/A |
|
||||
| HIPAA Authorization | ☐ or N/A |
|
||||
| Recruitment Materials | ☐ or N/A |
|
||||
| Surveys/Questionnaires | ☐ or N/A |
|
||||
| Training Certificates | ☐ |
|
||||
| COI Disclosures | ☐ |
|
||||
| Grant/Funding Documents | ☐ or N/A |
|
||||
| Investigator Brochure | ☐ or N/A |
|
||||
| Site Authorization Letters | ☐ or N/A |
|
||||
| Data Use Agreement | ☐ or N/A |
|
||||
| Other: _____________ | ☐ |
|
||||
|
||||
---
|
||||
|
||||
## Section 16: PI Assurance
|
||||
|
||||
By signing below, I certify that:
|
||||
|
||||
- I have read and will comply with all institutional policies and federal regulations
|
||||
- All information in this application is accurate and complete
|
||||
- I will obtain IRB approval before initiating any changes
|
||||
- I will report adverse events and unanticipated problems promptly
|
||||
- I will ensure all study personnel are appropriately trained
|
||||
- I take responsibility for the conduct of this research
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| PI Signature | |
|
||||
| Date | |
|
||||
|
||||
---
|
||||
|
||||
## Section 17: Department Approval (if required)
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Department Chair/Designee | |
|
||||
| Signature | |
|
||||
| Date | |
|
||||
|
||||
---
|
||||
|
||||
## For IRB Use Only
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Date Received | |
|
||||
| IRB Protocol Number | |
|
||||
| Review Category Assigned | ☐ Exempt ☐ Expedited ☐ Full Board |
|
||||
| Primary Reviewer | |
|
||||
| Secondary Reviewer | |
|
||||
| Meeting Date (if Full Board) | |
|
||||
| Action | |
|
||||
| Approval Date | |
|
||||
| Expiration Date | |
|
||||
|
||||
---
|
||||
|
||||
*Form FRM-IRB-001 Rev 1.0 - IRB Protocol Submission Form*
|
||||
72
Forms/Training/FRM-004-Training-Record.md
Normal file
72
Forms/Training/FRM-004-Training-Record.md
Normal file
@@ -0,0 +1,72 @@
|
||||
# Training Record Form
|
||||
|
||||
| Form ID | FRM-004 | Revision | 1.0 |
|
||||
|---------|---------|----------|-----|
|
||||
|
||||
---
|
||||
|
||||
## Section 1: Employee Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Employee Name | |
|
||||
| Employee ID | |
|
||||
| Department | |
|
||||
| Job Title | |
|
||||
|
||||
## Section 2: Training Information
|
||||
|
||||
| Field | Entry |
|
||||
|-------|-------|
|
||||
| Training Title | |
|
||||
| Training Date | |
|
||||
| Training Duration | |
|
||||
| Trainer Name | |
|
||||
| Trainer Qualification | |
|
||||
|
||||
### Training Type
|
||||
- [ ] Initial Training
|
||||
- [ ] Retraining
|
||||
- [ ] Refresher
|
||||
- [ ] Procedure Update
|
||||
|
||||
### Delivery Method
|
||||
- [ ] Classroom
|
||||
- [ ] On-the-Job
|
||||
- [ ] Self-Study
|
||||
- [ ] Computer-Based
|
||||
- [ ] Other: ____________
|
||||
|
||||
## Section 3: Training Content
|
||||
|
||||
*(List topics covered or attach training materials)*
|
||||
|
||||
|
||||
|
||||
|
||||
## Section 4: Assessment
|
||||
|
||||
### Assessment Method
|
||||
- [ ] Written Test
|
||||
- [ ] Practical Demonstration
|
||||
- [ ] Verbal Assessment
|
||||
- [ ] Observation
|
||||
|
||||
### Assessment Results
|
||||
|
||||
| Metric | Result |
|
||||
|--------|--------|
|
||||
| Score (if applicable) | |
|
||||
| Pass/Fail | |
|
||||
|
||||
## Section 5: Signatures
|
||||
|
||||
| Role | Name | Signature | Date |
|
||||
|------|------|-----------|------|
|
||||
| Trainee | | | |
|
||||
| Trainer | | | |
|
||||
| Supervisor | | | |
|
||||
|
||||
---
|
||||
|
||||
*Form FRM-004 Rev 1.0*
|
||||
Reference in New Lab Ticket
Block a user